10x Genomics, Inc. - Common Stock — Stato Patrimoniale (NASDAQ:TXG)

Financials

Totale attivo 929.34 M1.02 B1.03 B965.14 M918.64 M1.04 B Totale passività 190.27 M201.26 M223.24 M224.1 M208.5 M245.04 M Patrimonio netto totale 739.07 M817.57 M805.74 M741.04 M710.13 M796.33 M Totale passività e patrimonio netto 929.34 M1.02 B1.03 B965.14 M918.64 M1.04 B Debito totale 0————— Indebitamento netto 0—————

10x Genomics, Inc. - Common Stock

10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.

TXG

Financials

10x Genomics, Inc. - Common Stock

Notizie

Il titolo di 10x Genomics raggiunge il massimo a 52 settimane a 26,56 USD

10x Genomics, Inc. (TXG) Presents at Bank of America Global Healthcare Conference 2026 Transcript

10x Genomics Q1 Earnings & Revenues Beat Estimates, Gross Margin Up

10x Genomics, Inc. (TXG) Q1 2026 Earnings Call Transcript

10x Genomics (TXG) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

10x Genomics (TXG) Reports Q1 Loss, Beats Revenue Estimates

Torex Gold Q1 2026: margini record e $157M di free cash flow

PacBio Pre-Q1 Analysis: Time to Buy, Hold or Sell the Stock Now?

Hims & Hers Health, Inc. (HIMS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

10x Genomics (TXG) Expected to Beat Earnings Estimates: Should You Buy?

Tempus AI Stock Before Q1 Earnings Release: To Buy or Not to Buy?

Labcorp Gears Up to Report Q1 Earnings: What's in Store?